| FIDELITY FUNDS-EMERGING MARKETS I-ACC-EUR | RVI EMERGENTES | 16,020000 | 24/09/2026 | 34,28% | 88,40% | **** |
| UBS (IRL) INVESTOR SELECTION - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) P-ACC | RVI EMERGENTES | 223,354658 | 23/09/2026 | 34,28% | 86,56% | *** |
| ARTEMIS FUNDS (LUX) - SMARTGARP GLOBAL EMERGING MARKETS EQUITY FI GBP CAP | RVI EMERGENTES | 3,121590 | 22/09/2026 | 34,26% | 96,30% | ***** |
| UBS (IRL) INVESTOR SELECTION - GLOBAL EMERGING MARKETS OPPORTUNITY (GBP) P-ACC | RVI EMERGENTES | 320,942408 | 23/09/2026 | 34,26% | 87,19% | *** |
| ARTEMIS FUNDS (LUX) - SMARTGARP GLOBAL EMERGING MARKETS EQUITY B USD CAP | RVI EMERGENTES | 2,168106 | 22/09/2026 | 34,25% | 95,08% | **** |
| CT (LUX) ASIAN EQUITY INCOME DUP USD | RVI ASIA EX-JAPÓN | 15,390780 | 24/09/2026 | 34,25% | 56,52% | ** |
| VERITAS ASIAN FUND C USD CAP | RVI ASIA EX-JAPÓN | 918,645289 | 24/09/2026 | 34,24% | · | ND |
| VERITAS ASIAN FUND D USD DIS | RVI ASIA EX-JAPÓN | 884,783760 | 24/09/2026 | 34,24% | · | ND |
| XTRACKERS MSCI GENOMIC HEALTHCARE INNOVATION UCITS ETF 1C | RVI BIOTECNOLOGÍA | 39,525029 | 24/09/2026 | 34,24% | 53,69% | ** |
| INVESCO BLOOMBERG COMMODITY UCITS ETF EUR HEDGED ACC | RVI MATERIAS PRIMAS | 71,925600 | 18/09/2026 | 34,23% | 46,22% | ** |
